13yr old after swimming in a pool presented with vomitings on the same day with fever with bulbar palsy with opthalmoplegia with ptosis on ventilator with normal sensorium
"Naegleria fowleri" meningoencephalitis treatment
| Feature | This Patient | PAM |
|---|---|---|
| Age | 13 years | Median age 14 yrs (range 1 month–85 yrs) |
| Exposure | Swimming pool | Swimming in warm freshwater/poorly maintained pools |
| Onset | Same day | 2–15 day incubation (can be rapid) |
| Fever | Present | Universal — high fever |
| Vomiting | Present | Nausea and vomiting — cardinal feature |
| Cranial nerve palsies | CN III/IV/VI (ptosis + ophthalmoplegia) + bulbar | CN III, IV, VI palsies are common |
| Sensorium | Normal (early) | Initially preserved; progresses to coma |
| Ventilator-dependent | Present | Rapid respiratory compromise requiring ventilation |
"After an incubation period of 2–15 days, severe headache, high fever, nausea, vomiting, and meningismus develop. Photophobia and palsies of the third, fourth, and sixth cranial nerves are common. Rapid progression to seizures and coma may follow. The prognosis is uniformly poor: most patients die within a week." — Harrison's Principles of Internal Medicine 22E, 2025
| Test | Expected Finding in PAM |
|---|---|
| CSF wet mount | Motile trophozoites — diagnostic |
| CSF cell count | High WBC (up to 20,000/μL) — neutrophilic |
| CSF protein | Elevated |
| CSF glucose | Low |
| CSF Gram stain/culture | Negative for bacteria |
| CSF PCR (CDC) | Positive for N. fowleri |
| Brain MRI | Diffuse enhancement, particularly olfactory bulbs, basal ganglia |
| Serology | Not useful (antibodies found in healthy adults) |
| Drug | Role |
|---|---|
| Miltefosine (Impavido) | Most critical — only drug shown in all 7 worldwide survivors; alkylphosphocholine amoebicidal |
| Amphotericin B liposomal (IV + intrathecal) | Primary amoebicidal |
| Fluconazole | Synergistic |
| Azithromycin | Synergistic |
| Rifampin | Synergistic |
| Dexamethasone | Reduce neuroinflammation |
"All seven survivors among reported worldwide cases (381) included miltefosine as well as the five drugs above. Early diagnosis, prompt combination therapy including miltefosine, and aggressive management of neurologic complications, including therapeutic hypothermia, are important factors in better outcomes." — Harrison's 22E
13yo + fever + vomiting + swimming pool + CN III/IV/VI palsies + bulbar palsy + ventilator + NORMAL SENSORIUM
│
↓
PRIMARY AMOEBIC MENINGOENCEPHALITIS (Naegleria fowleri) — MOST LIKELY
│
↓
URGENT: Fresh CSF wet mount for motile trophozoites
+ CDC PCR (call CDC immediately)
│
↓
START EMPIRIC TREATMENT WITHOUT WAITING:
Miltefosine + Liposomal AmB + Fluconazole + Azithromycin + Rifampin + Dexamethasone
+ Therapeutic hypothermia
Sources: Harrison's Principles of Internal Medicine 22E (2025); Bradley & Daroff's Neurology in Clinical Practice; Medical Microbiology 9e; Tintinalli's Emergency Medicine; Red Book 2021
Without meningismus
| Feature | This Patient | Botulism |
|---|---|---|
| Ptosis | ✅ | Classic — first cranial nerve sign |
| Ophthalmoplegia (CN III/IV/VI) | ✅ | Characteristic bilateral cranial palsies |
| Bulbar palsy (dysarthria, dysphagia) | ✅ | Descending cranial → bulbar pattern |
| Normal sensorium (fully awake) | ✅ | Brain is unaffected — pathognomonic |
| Ventilator required | ✅ | Respiratory muscle paralysis |
| No meningismus | ✅ | No CNS inflammation whatsoever |
| Vomiting | ✅ | Autonomic involvement; also foodborne prodrome |
| Swimming pool | ✅ | Wound botulism from water/soil contact |
"The distinct syndrome of bilateral cranial palsies and descending flaccid paralysis in a fully conscious patient should render the diagnosis of botulism straightforward." — Harrison's Principles of Internal Medicine 22E
"No fever or other signs of infection occur [in classic botulism]. A slower moving form of the disease occurs when the toxin is produced endogenously in the intestinal tract or a wound." — Sherris & Ryan's Medical Microbiology 8e
C. botulinum toxin (metalloproteinase)
↓
Cleaves SNARE proteins at presynaptic membrane
↓
Blocks ACh release at NMJ
↓
Descending flaccid paralysis:
CRANIAL NERVES FIRST (CN III/IV/VI → ptosis + ophthalmoplegia)
↓
BULBAR (CN IX/X/XII → dysphagia, dysarthria, dysphonia)
↓
RESPIRATORY MUSCLES (diaphragm + intercostals → ventilator)
↓
LIMB WEAKNESS (late)
*** Brain unaffected → Normal sensorium throughout ***
*** No meningeal inflammation → No neck stiffness ***
| Test | Expected in Wound Botulism |
|---|---|
| Serum botulinum toxin assay (mouse bioassay) | Positive — gold standard |
| Wound culture | C. botulinum growth under anaerobic conditions |
| CSF | Normal — protein, glucose, cells all normal |
| EMG/NCS | Facilitating pattern on rapid repetitive stimulation (incremental response), reduced CMAP amplitude |
| CT/MRI brain | Normal |
| Acetylcholine receptor antibodies | Negative (rules out MG) |
| Anti-GQ1b antibodies | Negative (rules out MFS) |
| Edrophonium (Tensilon) test | Negative in botulism |
Descending cranial nerve palsies (ptosis → ophthalmoplegia → bulbar) + respiratory failure requiring ventilation + fully conscious patient + NO meningism
First is bulbar
"pharyngeal-cervical-brachial" variant Guillain-Barre syndrome
PMID: 25072194
Bulbar (CN IX/X/XII) FIRST
↓
Ophthalmoplegia + Ptosis (CN III/IV/VI) NEXT
↓
Respiratory failure (ventilator)
↓
Normal sensorium | No meningismus | Fever | Post-swimming
"GBS with severe bulbar and facial paralysis, sometimes associated with antecedent cytomegalovirus (CMV) infection and anti-GM2 antibodies" — as a regional GBS variant
| Pattern | Direction | Diagnosis |
|---|---|---|
| CN III/IV/VI → Bulbar → Limbs | Descending | Botulism |
| Bulbar → CN III/IV/VI → Limbs | Ascending / caudal→rostral | PCB-GBS, MFS-GBS overlap |
| Bulbar + CN III/IV/VI simultaneously | Diffuse brainstem | Brainstem encephalitis (BBE, rhombencephalitis) |
| Bulbar + CN III/IV/VI + altered consciousness | Brainstem | Bickerstaff's |
| Test | Expected Finding |
|---|---|
| CSF | Elevated protein, NO pleocytosis (albuminocytologic dissociation) |
| Anti-GT1a IgG | Positive → confirms PCB variant |
| Anti-GQ1b IgG | Positive → confirms MFS/BBE |
| Anti-GM2 IgG | Positive → GBS with bulbar/cranial involvement post-CMV |
| Nerve conduction studies | Demyelinating pattern (prolonged distal latencies, reduced conduction velocity) or axonal |
| MRI brain/brainstem | Normal (PCB/MFS) or brainstem T2 hyperintensity (BBE) |
| Stool/serology | Campylobacter jejuni, CMV, EBV |
| EMG | Reduced CMAP, absent/reduced F waves |
Bulbar-first then ophthalmoplegia = ascending cranial nerve pattern = PCB-GBS or MFS-GBS overlapOphthalmoplegia-first then bulbar = descending pattern = BotulismThe direction of cranial nerve involvement is the single most important localizing clue in this presentation.
Palatal tremors vs palatal myoclonus
| Feature | Essential Palatal Tremor (EPT) | Symptomatic Palatal Tremor (SPT) |
|---|---|---|
| Old name | Essential palatal myoclonus | Symptomatic palatal myoclonus |
| Muscle involved | Tensor veli palatini (CN V₃) | Levator veli palatini (CN X) |
| Ear click | ✅ Present — characteristic (opens Eustachian tube) | ❌ Absent |
| Persists during sleep | ❌ Disappears with sleep | ✅ Persists during sleep |
| Associated movements | Palate only | Palate + pharynx + face + eyes + diaphragm + neck/shoulders |
| Pendular nystagmus | ❌ Absent | ✅ May be present (synchronized) |
| MRI brain | Normal — no lesion | Inferior olivary pseudohypertrophy (hallmark) |
| Brainstem lesion | None | ✅ Central tegmental tract lesion |
| Guillain-Mollaret triangle | Not involved | ✅ Disrupted — key pathology |
| Etiology | Unknown / functional | Vascular, demyelinating, neoplastic, traumatic |
| Frequency | Variable; often higher | Variable but tends to be fixed |
| Functional/psychogenic | More likely | Less likely |
| Onset after injury | — | Months of latency before tremor appears |
Contralateral Dentate Nucleus (cerebellum)
↓ (superior cerebellar peduncle / brachium conjunctivum)
Ipsilateral Red Nucleus (midbrain)
↓ (Central Tegmental Tract — CTT)
Ipsilateral Inferior Olivary Nucleus (medulla)
↓ (inferior cerebellar peduncle / climbing fibers)
Back to Dentate Nucleus
With unilateral palatal tremor → it is the contralateral olive that enlarges (because the CTT crosses: lesion on one side → contralateral olive disinhibited)
| Essential (EPT) | Symptomatic (SPT) | |
|---|---|---|
| Ear click | ✅ Yes | ❌ No |
| Sleep | Disappears | Persists |
| Muscle | Tensor veli palatini | Levator veli palatini |
| MRI | Normal | Olivary pseudohypertrophy |
| Cause | Unknown | Guillain-Mollaret triangle lesion |
| Other movements | No | Yes (eyes, face, diaphragm) |
| Agent | Use |
|---|---|
| Gabapentin | Best evidence; "dramatic effect" in some cases |
| Clonazepam | 0.25–0.5 mg → up to 6 mg/day |
| Sodium valproate | 250 mg → up to 1000 mg/day |
| Tetrabenazine / Haloperidol | Occasionally helpful |
| Botulinum toxin (local injection) | Modest relief; best for ear click in EPT |
"Selective injection of the palatal muscles with botulinum toxin, while technically demanding, affords modest relief; it is particularly helpful in eliminating the bothersome ear clicking." — Adams & Victor's Neurology 12e
Essential = Ear click, Extinguished in sleep, Extra-normal MRI, Etiologically unknownSymptomatic = Sleep-persistent, Synchronized with nystagmus, Striking olivary hypertrophy, Secondary to Guillain-Mollaret triangle lesion
Rhombencephalitis
| Structure Involved | Clinical Features |
|---|---|
| Pons | CN V (facial sensory loss), CN VI (lateral gaze palsy), CN VII (facial palsy), CN VIII (hearing, vertigo), long tract signs |
| Medulla | CN IX/X (bulbar palsy — dysphagia, dysarthria, dysphonia), CN XII (tongue weakness), respiratory failure |
| Cerebellum | Ataxia (gait, limb), dysmetria, nystagmus |
| Midbrain (if involved) | CN III/IV palsy, altered consciousness |
| General brainstem | Diplopia, internuclear ophthalmoplegia, autonomic instability |
| Organism | Notes |
|---|---|
| Listeria monocytogenes | Classic cause — "rhombencephalitis" is almost synonymous with Listeria; predilects brainstem; asymmetric cranial nerve palsies; CSF often mildly abnormal or even normal; MRI shows brainstem T2 signal; meningeal signs in only 50% |
| Burkholderia pseudomallei | Melioidosis — similar to Listeria; endemic in India/Southeast Asia; multiple small abscesses in cerebellum and white matter |
| Mycobacterium tuberculosis | Basal meningitis → brainstem involvement by exudate; cranial nerve palsies common |
| Brucella | Neurobrucellosis; chronic form |
| Treponema pallidum | Neurosyphilis |
| Virus | Notes |
|---|---|
| Enterovirus 71 (EV71) | Children; follows hand-foot-mouth disease; brainstem encephalitis with myoclonic jerks + limb trembling; MRI: brainstem lesions; can progress to pulmonary edema/hemorrhage; most deaths in children ≤5 years |
| HSV-1 / HSV-2 | Usually temporal lobe but brainstem forms occur; recurrent brainstem encephalitis described with HSV-2 |
| EBV, CMV | Post-infectious; immunocompromised |
| Rabies | Brainstem + spinal cord syndromes |
| Tick-borne encephalitis virus | Brainstem/cerebellar involvement |
| West Nile Virus | Brainstem encephalitis, flaccid paralysis |
| SARS-CoV-2 | Rare brainstem involvement |
| Organism | Notes |
|---|---|
| Cryptococcus | Basilar meningitis → brainstem |
| Aspergillus | Angioinvasive; immunocompromised |
| Entity | Key Features |
|---|---|
| Bickerstaff Brainstem Encephalitis (BBE) | Ophthalmoplegia + ataxia + impaired consciousness (distinguishes from MFS); anti-GQ1b antibodies; MRI: T2 brainstem/thalamic hyperintensity or normal; treat as GBS spectrum (IVIg/plasma exchange) |
| CLIPPERS | Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids; subacute ataxia, diplopia, dysarthria; MRI: punctate gadolinium enhancement in pons/cerebellum; responds dramatically to steroids |
| Anti-NMDAR encephalitis | Usually limbic but brainstem forms |
| Neurosarcoidosis | Cranial nerve palsies, hypothalamic involvement |
| CNS vasculitis | |
| Multiple sclerosis | Brainstem demyelinating plaques |
| Paraneoplastic | Anti-Hu, anti-Ri (brainstem/cerebellar) |
| Feature | Listeria Rhombencephalitis | EV71 Rhombencephalitis |
|---|---|---|
| Age | Elderly, immunocompromised, neonates | Young children (≤5 years) |
| Preceding illness | None / subtle GI | HFMD (hand-foot-mouth disease) |
| Onset pattern | Biphasic — prodrome then CN palsies | Acute |
| CN palsies | Asymmetric, multiple | Present |
| Myoclonus/tremor | Less typical | ✅ Characteristic — myoclonic jerks, limb trembling |
| Autonomic storm | Less prominent | ✅ Common — tachycardia, hypertension |
| CSF | Mild pleocytosis or normal | Mild lymphocytic pleocytosis |
| MRI | T2 brainstem lesions | Brainstem, dorsal pons/medulla lesions |
| Blood cultures | Positive in >75% | Negative |
| Treatment | Ampicillin + Gentamicin | Supportive |
| Mortality | ~30% | High in severe cases |
"A brainstem disorder often confused with infection is Bickerstaff's brainstem encephalitis. Patients with this disorder have often had a preceding systemic viral infection, then acutely develop ataxia, ophthalmoplegia, long-tract signs, and alterations of consciousness including coma." — Plum & Posner's Diagnosis and Treatment of Stupor and Coma
| Test | Significance |
|---|---|
| MRI brain (FLAIR/T2/DWI) | T2 hyperintensity in brainstem/cerebellum; always first |
| CSF | Cell count, protein, glucose, culture, PCR (HSV, EV, CMV) |
| Blood cultures × 3 | Positive in >75% of Listeria — do before antibiotics |
| Anti-GQ1b antibodies | BBE / MFS |
| Anti-GT1a antibodies | PCB-GBS variant |
| EV71 PCR | Throat swab, stool, CSF |
| Listeria PCR | CSF or blood |
| Brucella serology | Endemic areas |
| Cause | Treatment |
|---|---|
| Listeria | Ampicillin 2g IV q4h + Gentamicin (penicillin allergy: TMP-SMX) |
| Burkholderia (Melioidosis) | Ceftazidime or meropenem → maintenance cotrimoxazole |
| HSV | Acyclovir 10mg/kg IV q8h |
| EV71 | Supportive; milrinone for autonomic storm |
| BBE / GBS spectrum | IVIg 2g/kg over 5 days or plasmapheresis |
| CLIPPERS | High-dose corticosteroids → immunosuppression maintenance |
| TB | Anti-tubercular therapy + steroids |
RHOMBENCEPHALITIS
│
├─ INFECTIOUS
│ ├─ Bacterial: Listeria ★ (classic), Melioidosis, TB, Brucella
│ ├─ Viral: Enterovirus 71 ★ (children), HSV-2, Rabies, Tick-borne
│ └─ Fungal: Cryptococcus, Aspergillus
│
├─ AUTOIMMUNE / PARA-INFECTIOUS
│ ├─ Bickerstaff Brainstem Encephalitis (anti-GQ1b) ★
│ ├─ CLIPPERS (pontine perivascular)
│ ├─ Paraneoplastic (anti-Hu, anti-Ri)
│ └─ MS / neurosarcoidosis
│
└─ EMPIRIC APPROACH (while awaiting results)
├─ Cover Listeria: Ampicillin + Gentamicin
├─ Cover HSV: Acyclovir
└─ Consider IVIg if anti-GQ1b pending (BBE)
Sources: Adams & Victor's Principles of Neurology 12e; Bradley & Daroff's Neurology in Clinical Practice; Harrison's Principles of Internal Medicine 22E; Plum & Posner's Diagnosis and Treatment of Stupor and Coma; Localization in Clinical Neurology 8e
Generalised dystonia in 20yr old from 5 years
| Feature | This Patient |
|---|---|
| Age at onset | Adolescence (13–20 years) |
| Body distribution | Generalised |
| Temporal pattern | Progressive (5 years) |
| Variability | Persistent |
| Category | Examples relevant here |
|---|---|
| Inherited | DYT1, DYT2, DYT5, DYT6, DYT17, Wilson disease, PKAN |
| Acquired | Perinatal injury, drugs, infection, vascular, psychogenic |
| Idiopathic | No structural or degenerative pathology found |
| Gene/DYT | Name | Inheritance | Onset | Features |
|---|---|---|---|---|
| DYT1 / TOR1A | Oppenheim dystonia (Early-onset primary torsion dystonia) | AD (30% penetrance) | 6–12 yrs (can extend to adolescence) | Starts in one foot/leg while walking → spreads to generalised; Chr 9q; Torsin A protein; no cognitive/intellectual involvement |
| DYT2 | AR primary torsion dystonia | AR | Childhood–adolescence | Similar to DYT1; consanguineous families |
| DYT6 / THAP1 | Adolescent-onset mixed torsion dystonia | AD | Adolescence | Upper limb or cranial onset; dysphonia prominent; German-Mennonite origin |
| DYT17 | Adolescent-onset AR torsion dystonia | AR | Adolescence | Rare |
DYT1 is the most common inherited generalised dystonia. It begins in one limb (usually a leg/foot during walking), progresses over years to become generalised. Adolescent onset at 15 is within range.
| Disease | Key Feature | Test |
|---|---|---|
| Wilson disease | Liver + neuro + KF rings | Ceruloplasmin, 24hr urine Cu, MRI |
| PKAN (NBIA type 1) | "Eye of the tiger" MRI sign (GPi); PANK2 mutation; AR | MRI brain (T2 GPi hypointensity with central hyperintensity) |
| Neuroacanthocytosis | Orolingual dystonia, chorea, self-mutilation, areflexia | Blood film (acanthocytes), VPS13A gene |
| Huntington disease (juvenile) | Akinetic-rigid or dystonic form; cognitive decline | CAG repeat ≥55; family history |
| DRPLA | Ataxia + myoclonus + dystonia + dementia | Genetic testing |
| GM1/GM2 gangliosidosis | Cherry-red spot, cognitive decline | Enzyme assay |
| Metachromatic leukodystrophy | White matter disease, MRI periventricular changes | Arylsulfatase A |
| Niemann-Pick C | Vertical supranuclear gaze palsy, ataxia | Filipin staining, NPC1/2 |
| Lesch-Nyhan syndrome | Self-mutilation, hyperuricaemia (males only) | HPRT enzyme activity |
| Type | Gene | Hallmark |
|---|---|---|
| PKAN (NBIA-1) | PANK2 | "Eye of the tiger" sign on T2 MRI in globus pallidus |
| MPAN | C19orf12 | |
| BPAN | WDR45 | X-linked; females; regression then parkinsonism |
| FA2H | Fatty acid hydroxylase |
| Test | Target |
|---|---|
| MRI brain (T1, T2, FLAIR, SWI) | Structural/degenerative, iron (PKAN), Wilson changes |
| Serum ceruloplasmin | Wilson disease |
| 24-hr urinary copper | Wilson disease |
| Slit-lamp examination | Kayser-Fleischer rings (Wilson) |
| Liver function tests | Wilson (hepatic involvement) |
| Levodopa trial | DRD — must be tried in ALL young-onset dystonia |
| Test | Target |
|---|---|
| Serum copper | Wilson |
| Blood film (acanthocytes) | Neuroacanthocytosis, HARP syndrome |
| Lysosomal enzyme panel | Gangliosidoses, MLD |
| Very long chain fatty acids | Adrenoleukodystrophy |
| Urine amino acids + organic acids | Organic acidaemias (glutaric, methylmalonic) |
| Arylsulfatase A | MLD |
| Filipin staining / NPC1 gene | Niemann-Pick C |
| HPRT enzyme | Lesch-Nyhan |
| Uric acid | Lesch-Nyhan |
| Lactate, pyruvate | Mitochondrial disease |
| Gene Panel | When |
|---|---|
| DYT1 (TOR1A) deletion | Young-onset generalised, no secondary cause found |
| DYT6 (THAP1) | Adolescent onset, prominent cervical/laryngeal involvement |
| GCH1 (DRD) | If levodopa trial response uncertain |
| PANK2 | "Eye of tiger" on MRI |
| ATP7B | Wilson disease confirmation |
| Whole exome sequencing | If targeted panel negative |
| Drug | Mechanism | Use |
|---|---|---|
| Trihexyphenidyl (anticholinergic) | Blocks muscarinic receptors | High-dose (up to 20–30 mg/day in young) — most effective for primary generalised dystonia |
| Baclofen | GABA-B agonist | Adjunct; intrathecal baclofen for severe cases |
| Clonazepam | GABAergic | Adjunct |
| Tetrabenazine | Dopamine depleter | For hyperkinetic component |
| Valproate | GABAergic | Adjunct |
| D-penicillamine / Trientine / Zinc | Copper chelation | Wilson disease — specific treatment |
| Biotin + Thiamine | Cofactor replacement | BBGD |
A levodopa trial is mandatory in every young-onset generalised dystonia — DRD is treatable and mimics all other forms Wilson disease must be excluded urgently — it is the most common treatable secondary cause in this age group MRI with SWI/T2 — look for "eye of the tiger" (PKAN) and Wilson changes (putaminal T2 changes, "face of panda") Adolescent-onset generalised → DYT1 (TOR1A) is most likely primary cause if secondary workup negative GPi-DBS is the most effective intervention for medication-refractory primary generalised dystonia
Amoebic meningoencephalitis
| Genus | CNS Syndrome |
|---|---|
| Naegleria fowleri | Primary Amoebic Meningoencephalitis (PAM) |
| Acanthamoeba spp. | Granulomatous Amoebic Encephalitis (GAE) + Keratitis |
| Balamuthia mandrillaris | Granulomatous Amoebic Encephalitis (GAE) |
| Sappinia pedata | GAE (single case reported) |
Warm freshwater inhaled nasally
↓
Trophozoites enter olfactory neuroepithelium
↓
Migrate along olfactory nerve → cribriform plate
↓
Enter CNS, bypass blood-brain barrier
↓
Fulminant necrotizing hemorrhagic encephalitis
↓
Neutrophilic response — olfactory bulbs/frontal lobes first
↓
Diffuse cerebral edema, uncal herniation → death (median <10 days)
| Feature | Details |
|---|---|
| Incubation | 2–15 days |
| Fever | High, universal |
| Headache | Severe |
| Nausea/vomiting | Present early |
| Meningismus | Usually present (mimics bacterial meningitis) |
| Photophobia | Common |
| CN III, IV, VI palsies | Frequent |
| Seizures | Progressive |
| Coma | Rapid progression |
| Uncal herniation | Terminal event |
| Death | ~10 days from exposure; mortality >97% |
| Parameter | Result |
|---|---|
| Opening pressure | Elevated |
| Appearance | Haemorrhagic / purulent |
| WBC | High — neutrophilic (up to 20,000/µL) |
| Protein | Elevated |
| Glucose | Low |
| Gram stain / culture | Negative for bacteria |
| Wet mount | Motile trophozoites — diagnostic |
Critical: CSF must be examined immediately as a fresh wet preparation — trophozoites are motile and die if refrigerated. This is the bedside diagnostic.
| Test | Notes |
|---|---|
| Fresh CSF wet mount | Motile trophozoites (10–35 µm) — diagnostic |
| CDC PCR | Most sensitive; call CDC (770-488-7100) |
| Histochemical staining of biopsy | Available via CDC |
| MRI | Obliteration of cisterns, diffuse enhancement; olfactory bulb involvement |
| Serology | Not useful — antibodies found in healthy adults |
| Drug | Role |
|---|---|
| Miltefosine (Impavido) | Central — all survivors received this; alkylphosphocholine; crosses BBB |
| Liposomal Amphotericin B (IV + intrathecal) | Primary amoebicidal |
| Fluconazole | Synergistic |
| Azithromycin | Synergistic |
| Rifampin | Synergistic |
| Dexamethasone | Neuroinflammation / cerebral edema |
| Therapeutic hypothermia | Associated with survival |
| Feature | Acanthamoeba | Balamuthia mandrillaris |
|---|---|---|
| Host | Usually immunocompromised | Can affect immunocompetent |
| Risk factors | AIDS, transplant, steroids, lymphoma, lupus | Young age, Hispanic ethnicity, soil/water exposure |
| Entry route | Inhalation or skin contact → haematogenous | Percutaneous or mucous membrane → haematogenous |
| Onset | Subacute/chronic (weeks to months) | Subacute — weeks to months |
| Skin lesions | Cutaneous ulcers/nodules (especially AIDS) | Face/trunk/extremity skin lesions — early clue |
| CNS | Mimics space-occupying lesion | Focal deficits, seizures, headache, fever |
| CSF | Mononuclear pleocytosis; elevated protein | Mononuclear or neutrophilic pleocytosis; elevated protein; normal-low glucose |
| Amoebae in CSF | Rare | Rarely isolated |
| Brain imaging | Multiple hypodense/enhancing lesions; mimics toxoplasmosis | Multiple hypodense lesions |
| Diagnosis | Biopsy — trophozoites + cysts; culture on E. coli-seeded agar | CSF, biopsy; CDC PCR; fluorescent antibody |
| Transplant transmission | Less documented | Yes — 3 clusters 2009–2012 |
| Survival | Very rare; accelerated course in AIDS/transplant (3–40 days) | 9 survivors in USA with aggressive treatment |
| Treatment | Miltefosine + combination | Pentamidine + flucytosine + sulfadiazine + macrolides + miltefosine |
| Feature | PAM (Naegleria) | GAE (Acanthamoeba / Balamuthia) |
|---|---|---|
| Onset | Acute/fulminant | Subacute/chronic |
| Host | Healthy, young, male | Immunocompromised (Acanthamoeba); any (Balamuthia) |
| Exposure | Warm freshwater swimming/nasal | Skin/soil/air → haematogenous |
| Entry | Olfactory neuroepithelium | Haematogenous from skin/lung/sinus |
| Pathology | Necrotizing haemorrhagic encephalitis | Granulomatous encephalitis |
| CSF | Neutrophilic, haemorrhagic, motile trophozoites | Mononuclear; organisms rarely seen |
| Meningismus | Present (like bacterial meningitis) | Variable; less prominent |
| MRI | Diffuse oedema, cisternal obliteration | Multiple focal lesions (mimic tumour/abscess/toxoplasmosis) |
| Diagnosis | Fresh CSF wet mount (motile trophozoites) | Brain biopsy (trophozoites + cysts) |
| Course | Death in <10 days | Weeks to months |
| Mortality | >97% | >95% |
| Key treatment | Miltefosine + AmB + FLU + AZI + RIF + Dexa | Miltefosine + organism-specific combinations |


Young healthy person + warm freshwater swimming + acute meningitis-like illness
→ PAM (Naegleria) — CSF wet mount STAT
Immunocompromised + subacute focal brain lesions + skin nodules/ulcers
→ GAE (Acanthamoeba) — brain biopsy
Immunocompetent or immunocompromised + skin lesion on face + subacute encephalopathy
+ soil/water exposure or organ transplant recipient
→ GAE (Balamuthia) — CDC PCR + biopsy
Contact lens wearer + painful red eye + annular corneal ring
→ Acanthamoeba keratitis — corneal scraping for cysts
Sources: Harrison's Principles of Internal Medicine 22E; Robbins & Kumar Basic Pathology; Kaplan & Sadock's Comprehensive Textbook of Psychiatry; Medical Microbiology 9e; Tintinalli's Emergency Medicine
Hypertrophic olivary degeneration
"hypertrophic olivary degeneration" MRI clinical
PMID: 31026459
hypertrophic olivary degeneration MRI inferior olive T2
First described by Oppenheim in post-mortem studies; the enlarged ION was first correlated with clinical palatal myoclonus by Guillain and Mollaret.
MIDBRAIN
Red Nucleus (ipsilateral)
/ \
Central Tegmental Brachium Conjunctivum
Tract (CTT) (Superior Cerebellar Peduncle)
↓ ↑
MEDULLA CEREBELLUM
Inferior Olivary Dentate Nucleus
Nucleus (ION) (contralateral)
(ipsilateral)
↓ __________________|
Inferior Cerebellar
Peduncle (climbing fibers)
| Limb | Pathway | Direction |
|---|---|---|
| 1. Central Tegmental Tract (CTT) | Red nucleus → Inferior olive | Descending (ipsilateral) |
| 2. Superior Cerebellar Peduncle | Dentate nucleus → Red nucleus | Ascending (crosses at midbrain) |
| 3. Inferior Cerebellar Peduncle | Inferior olive → Dentate nucleus (climbing fibers) | Ascending (crosses) |
| Time from lesion | MRI finding |
|---|---|
| 0–1 month | No olivary change (normal MRI) |
| 1–6 months | T2 hyperintensity appears in ION (earliest sign) |
| 6 months–3–4 years | T2 hyperintensity + enlargement of ION (classic HOD) |
| >3–4 years | Enlargement resolves; T2 hyperintensity may persist or also regress |
The latency of months between the causative lesion and onset of palatal tremor / MRI changes is a hallmark of HOD.
| Cause | Notes |
|---|---|
| Brainstem infarction (most common) | CTT in pons/midbrain; posterior circulation strokes |
| Brainstem haemorrhage | Pontine haemorrhage is the most common single cause |
| Cerebellar infarction/haemorrhage | Dentate nucleus involvement |
| Neurosurgical procedures | Posterior fossa surgery; tumour resection |
| Tumours | Brainstem glioma, metastases, cavernomas |
| Demyelination | MS plaques in CTT |
| Trauma | Diffuse axonal injury |
| Lesion Site | HOD Laterality | Explanation |
|---|---|---|
| Unilateral CTT (pons/midbrain) | Contralateral ION hypertrophy | CTT descends ipsilaterally to the olive; olive projects contralaterally to the dentate; the "disinhibited" side is contralateral to the CTT lesion |
| Unilateral dentate nucleus | Ipsilateral ION hypertrophy | Dentato-rubro-olivary pathway |
| Both CTT + dentate nucleus (or crossing fibres) | Bilateral HOD | More complex lesions |
Rule: With unilateral palatal tremor, the contralateral olive enlarges. — Adams & Victor's Neurology 12e


| Condition | Key Differentiator |
|---|---|
| HOD | No enhancement; enlarged; delayed onset after GMT lesion; palatal tremor |
| Brainstem tumour | Enhancement; mass effect; no latency |
| Demyelinating plaque (MS) | Other white matter lesions; may enhance acutely |
| Wernicke encephalopathy | Mammillary bodies + periaqueductal gray + thalamus also involved |
| Osmotic demyelination | Pons centrally; history of hyponatraemia correction |
| Brainstem infarction (acute) | DWI restriction; acute onset |
| Symptomatic Palatal Tremor (= HOD) | Essential Palatal Tremor | |
|---|---|---|
| Muscle | Levator veli palatini | Tensor veli palatini |
| Ear click | ❌ No | ✅ Yes |
| Sleep | Persists | Disappears |
| MRI olive | Enlarged + T2 bright | Normal |
| GMT lesion | ✅ Present | ❌ None |
| Onset after lesion | Months | No prior lesion |
| Intervention | Notes |
|---|---|
| Gabapentin | Most effective (dramatic in some) |
| Clonazepam | 0.25–6 mg/day |
| Sodium valproate | 250–1000 mg/day |
| Memantine | Reported benefit (NMDA receptor modulation of olivary rhythmicity) |
| Botulinum toxin | Palatal injection — modest relief |
| Treat primary lesion | If vascular, manage risk factors |
| No cure | HOD itself is irreversible once established |
HOD = trans-synaptic degeneration of the inferior olive, occurring months after a lesion interrupts the Guillain-Mollaret triangle (red nucleus → central tegmental tract → inferior olive → dentate nucleus → back)MRI: T2/FLAIR hyperintensity + enlargement of ION, no gadolinium enhancement, delayed onset 1–6 months after causative lesionClinically: Symptomatic palatal tremor + pendular nystagmus ± rhythmic myoclonus of face/pharynx/diaphragmKey concept: The olive hypertrophies (not atrophies) because the process is astrocytic vacuolation and gap junction upregulation — not simple neuronal loss
How to ask for history in dementia for all lobes
Always obtain history from both patient AND a reliable informant (caregiver/family) — the patient may lack insight (anosognosia), especially in frontal or parietal disease.
Suggests: Frontotemporal dementia (bvFTD), non-fluent/agrammatic PPA, PSP, CBD
Suggests: Alzheimer's disease (medial temporal first), LATE, semantic variant PPA (anterior temporal), Wernicke's aphasia in PPA
Suggests: Posterior cortical atrophy (PCA — Alzheimer's variant), corticobasal degeneration, DLB (posterior parietal)
Suggests: DLB (vivid visual hallucinations), posterior cortical atrophy, CJD, occipital strokes
Suggests: Vascular dementia, Binswanger's, NPH, Huntington's, PSP
| Predominant Lobe | Earliest Symptoms | Common Diagnosis |
|---|---|---|
| Medial temporal | Episodic memory loss, repetition | Alzheimer's disease, LATE |
| Frontal | Personality, behaviour, disinhibition, apathy | FTD (bvFTD), PSP |
| Dominant temporal (anterior) | Word meaning loss, fluent empty speech | Semantic PPA |
| Dominant temporal (posterior) | Comprehension failure, fluent paraphasia | Wernicke's/logopenic PPA |
| Dominant frontal | Effortful, halting speech | Non-fluent PPA, CBS |
| Parietal + occipital | Visuospatial, apraxia, visual hallucinations | PCA, DLB, CBS |
| Subcortical + frontal | Slowing, gait, incontinence | Vascular, NPH |
| Multifocal/rapid | Any combination + rapid progression | CJD, autoimmune encephalitis |
| Domain | Questions |
|---|---|
| Onset | Sudden (vascular) vs gradual (degenerative) vs fluctuating (DLB) |
| Course | Progressive / stepwise (vascular) / relapsing |
| ADLs | Dressing, bathing, cooking, driving, finances, medications |
| Sleep | REM sleep behaviour disorder (punching/kicking in sleep) → DLB/PD |
| Falls | Repeated early falls → PSP |
| Hallucinations | Visual hallucinations early → DLB |
| Drugs | Anticholinergics, benzodiazepines, opioids |
| Risk factors | Hypertension, diabetes, smoking (vascular), family history |
| Mood | Depression can mimic and worsen dementia |
| Occupational history | Toxic exposures; head trauma (CTE) |
| Lobe | Signature Question |
|---|---|
| Frontal | "Has his personality changed? Does he do inappropriate things?" |
| Limbic/Temporal | "Does he repeat the same question within minutes?" |
| Parietal | "Does he get lost in familiar places? Can he still dress himself?" |
| Occipital | "Does he see things that aren't there?" |
| Temporal (semantic) | "Has he lost the meaning of words? Does he recognise familiar faces?" |
Sources: Harrison's Principles of Internal Medicine 22E (Table 33-4, Functional Anatomy of Dementias); Localization in Clinical Neurology 8e; Adams & Victor's Principles of Neurology 12e
Dystonia